Literature DB >> 7845845

The effect of exogenous adenosine in patients with neurally-mediated syncope and sick sinus syndrome.

M Brignole1, C Menozzi, P Alboni, D Oddone, L Gianfranchi, G Gaggioli, G Lolli, N Paparella.   

Abstract

The effects of a 20-mg i.v., bolus of adenosine 5' triphosphate (ATP) on the heart rhythm was studied in 79 patients affected by neurally-mediated syncope (26 cases) or sick sinus syndrome (22 cases) or both syndromes (31 cases) and in 31 healthy control subjects in order to examine the sensitivity of cardiac purinoceptors in such circumstances. During ATP infusion, the sinus cycle lengthened to > 2 seconds in no control, in 1 (4%) patient with neurally-mediated syncope, in 5 (23%) patients with sick sinus syndrome, and in 13 (42%) patients with both neurally-mediated and sick sinus syndromes (P = 0.01). Atrioventricular block occurred in 14 (45%) of controls, in 10 (38%) patients with neurally-mediated syncope, in 4 (18%) patients with sick sinus syndrome, and in 13 (42%) patients with both neurally-mediated syncope and sick sinus syndrome (n.s.). Thus, exogenous ATP exerts different effects on patients with neurally-mediated syncope and patients with sick sinus syndrome. In fact, intrisic disease of the sinus node is necessary to modulate an abnormal adenosine-mediated sinus arrest, whereas patients affected by neurally-mediated syncope alone show a normal sensitivity to the drug administration. The effect of ATP on atrioventricular conduction is greater than that on sinus node and is of similar magnitude in patients and controls; thus the clinical meaning of ATP induced atrioventricular block remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7845845     DOI: 10.1111/j.1540-8159.1994.tb03828.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  ATPace™: injectable adenosine 5'-triphosphate : Diagnostic and therapeutic indications.

Authors:  Amir Pelleg; Steven P Kutalek; Daniel Flammang; David Benditt
Journal:  Purinergic Signal       Date:  2011-11-06       Impact factor: 3.765

3.  Feasibility and safety of adenosine cardiovascular magnetic resonance in patients with MR conditional pacemaker systems at 1.5 Tesla.

Authors:  Oliver Klein-Wiele; Marietta Garmer; Rhyan Urbien; Martin Busch; Kaffer Kara; Serban Mateiescu; Dietrich Grönemeyer; Michael Schulte-Hermes; Marc Garbrecht; Birgit Hailer
Journal:  J Cardiovasc Magn Reson       Date:  2015-12-22       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.